Professional Documents
Culture Documents
AA 8-2會期部長業務報告-書面報告 PDF
AA 8-2會期部長業務報告-書面報告 PDF
()
1. 71
(100) 59
4 9
6 144 2 (
10 3 )
2. 101 3
23
3. 71
4. 101 72
5. 71
5
14
6.
()
1. 101 9 6 195
13 182
101 5 (122 )(58
)(1 ) (1 )
2.
3. 101
4. 101 3 20 21
5. 101 5 11
101 1
6.
101 4 5 8
2,490
()
1. 94-100
35.6%
2. (DOTS)
101 6
6,890
90%
3. X
101 6
2,855 2,031 99 1,797
4. (MDR) 96
5 100
101 6 78
5.
()
1. 101 6 2
3,081 101
3.
4.
101 1 6 4 0,275
5.
96
101 46
101 6
7,960
6. 101 6
21 () 928
415 1
101 1 6
23 2,480 311
90%
()
1. 100 266 7,665
100 10 1 101 6 30 258.2
97.86 101
297 5,365 101 10 1
65 6
6
102 1 1 50-64
2. 10-15%
100 12 1 101 3 31
3.
101 1 1 6 30
25 /
7
4.
101
101
8 16 1,247
8 10
9,561
()
1. 101
101 493 5
157
6 111 (70.7%)
2.
WHO 5 5 5
5 ( 5 )
3.
()
4. (Enterobacteriaceae)
5.
101
59 9
()
1. /
2. 101 4
9
MMR
Tdap-IPV
3. 101 5 PCV
4.3
102 2-5 PCV
4. 75
()
1.
100 9 16
3 63
50
4
2. 98
101 6
189 19
81 24
57 112
101 9
101
3.
9 17
24
2 13
10
3
15 21
28 24
()
1.
99 7 1
101 79
203 530
2.
101
39 1311
3.
14
101 6
11
131 1 3,322
4.
101 16 45
103 1 1
5. 101
10
()
1.
101 14
19,179
5
2.
109
104
96 1 4,131 100
3 6,628 94
71.5% 100 5%
3.
12
100
6.51 16.54
()
1.
101 22
292
101 6 126,271
188,605 1.52
44.21%
2. 97 7 4
99 1,696
95%100 1,211 96.12%
101 6 657 96.65%
99 27 100%100
40 97.5%101
101 6 35
88.57%
13
3. 100 3,507
10 15.1 95 4,406
19.3 899
20.4% 13
2 99 11 100 12
()
1. 101
14
2. 101 193
6
5
3. /98
58
4.
1 10
14
2 3
()
1. 5 (33
25100
26)
11
2. 101 1 1 103 12
31
200
15
3. 100
4.
5. ()
1
24
98.7
2
()
()
6.
45
4 5 4 6
5 10
16
1
2
3
4
5
6
3
4 103
5
6
7
8
9
10
17
1 102 1 49
22 55%
10
2 101
3 ()
100 200
101 7 9
101 9 11
101 9 1
4 100 11 1
101 6
22
5 101 7-9
18
7
skill mix
8
101
8 21
9 26
7.
1 101 7 10
() 101
2/3( 60 100 )
101
3 101 2
19
120
6
720
8.
1 101 6 4 6
2 95 100
2,918 ( 1,450 1,468 )
3 100 69
2,488 101 80
4 100
101
101 6 30 747
358 41
12 )9 9 911
440 43
12 416
9.
1 101 7
16
20
101 8
3 17
10
2 102
102
()
1.
2.
1
25
2 101 7 97 6
65 (56
7 1
1 ) 11 21
(
)
21
3. 24
95 3 101 8
3,484,795
4. 15 ( 25 ) CDC
61%
5.
1 101 ()
9 102
2 100 81
10,038
1,288 150
2 101
3 101 ()
11 100 3,286
1,530 11,048
4 101
102 16
5 2,000 (
1,497 227
216 3
)
22
6.
( 12 100 1 101
8 64,528 )
7. (
) ()
() (
)
()
1.
1
100
12 274
2
100
12 208
3
100
12 150
2.
100 12 IC 32
23
3.
101 6
189
175
()
1.
1
HIS
100
48 ( 30 18 )101
7
2 32 ( 23 9 )
(PACS)
3
100 19
101 1-8
4,623
4
24
2.
1 101 1 8 3
15
3
2 101 1 8
314 241
2 40
3.
101
86 1 8
2 9,815 9,535
30,809
1 4,821 875
3 9,579 3,200
4.
5.
25
101
40 26 9
1600
6.
100
776 101 31 ( 27 )
7.
24
101 1 8 201
94.37%
101
8.
9.
26
1 8 29
2 8 29 2
8 30 1
3 8 31
8 31 IDS
9 3
4
5 3,550
()
1.
1
27
3
5
2.
1
99 100 1
130 25 2
157
99 100
4,550
99 100
5,117 9667
2 ()
101
8
100 101 13
3.
1
28
100 61,675 97
3.5 101 8 37,622 100
61%
9,443
101 CDR
2 100
100
30 101
4.
7 7 8
7
8 1 2
101 2 23 7 12 9
6 95
5.
29
99
35
2.98%100
( 1 )
100 11
2
(
)
()
100 4
101
30
4
101 7
102 7
6 98 9 101 6
94
266
()
1. 99 4 1
99 3
604 101 6 95
2. ()
31
101 6
6.93
3.
101 6
306 1.19%
4.
7
100 12 1
()
1.
1 100
4.39
4.17 5.01%
4 5,511 4 5,366
32
145 0.32%
2 101 1 5
4.42
4.14 6.33%
4 5,953 4 5,264
689 1.50%
3
2.
1 100 7 1 7
15 101 1 17 6
1 6 11
3.
1 101
21.47
101 6 20
33
57114C 6
43 12.83
0.572
8.527
9% 4
2 6
3% 9.099
101 1 1
2 101 3.2
3 100 8
RBRVS 37
100 9 100 10
24
101 6 28
34
101
9 101
12
4.
(1)
(2)
(3)
3
101 6 384.3
()
1.
101 6 280
110
2.
1 101 6
1,927 1.15
7 17.48
1,518 1,165
2 101
101 6
1.37 3.18
35
3.
101 6 2,019
5,692
4.
1
101 6 42.1
18
17.8
17
7.3
2 37
5.
(IDS) 48 (40
)
36
101
25
4-6 (100
4.39 )
()
1.
90
99
150 ()
100 ()
5.7 99 100
32,468 100 12
17 16
6.2
2.
3. 98 12
101 193
37
46 100
0.15 12.5%
()
1. 100
1 4
100 1 26
1 2
2.
38
3 101 6
1
1
6
101 8 13 2348
( 118 )
()
1. 101 1 6 212
18 1,102
111
2. 101 2 6 4
39
30 1,510
734 609 51 47
47 10 12
16 2 1
1.3%
3.
61 612
4. 101
7 9 102
4 LC/MS/MS
5. 101 1 6 27
()
1.
1 101 8 8 11
17 1 31
40
2 101 1 6
167 )
7 7
73
2.
1 101 6
21 5,220
2 101 6
224
3
101 QSA 9
63.31%101 6
5,521 714 685
17 ()
101 3 20
100
7 1 424
41
101 6
8,375 97.7%
3.
1
http://fadenbook.fda.gov.tw/
101 8 13 435
8,628 101 4
400
2
101
6 28
101 7 9
42
4.
1 101 8 9
8 15
2 101 9 6
101 9 12
101 9 20
3 101 7 21
() ()
8
2
()
43
1. (cGMP) 101 6
160 ( 10 3
) 20 ( 151 ) GMP
40 PIC/S GMP
2. 101 6
685 97 64
3 30 98 64
3 30 10
7 3 480
3. 184
4 5
4. 101
6 52
5. 101 6
449 27
6.
6
7. 101 6 27
GMP
GMP
44
8. 101 4 26 3
9. 101 5 30
11. 20
309 4 PCNB
98.71%
12. 101 8 1
10
13. Wnt
1
2
14. 101 6
45
15.
4 14 5 5
35 4 14 11 30
10
()
1.
101
6 18
4
2.
(REMS)
3. 101 4 5
(REMS) 101 7
REMS 9 12 4
58
4.
4
5.
46
22 14
31 4
9
6.
71
()
1.
101 6 9,575
83 0.87%
2. 101 6
8,644 100 8,218
5.2%
()
1. 101 6
4,080
1,707.6 99 1
13.9% 101 6 4.08%
2. 99 3
99 1 3
190 216
47
43 149
21.9%
18.4 %
()
101 6
481
100 3 3
96
101 6
6 6
()
1. 10 1 100
186
94.04% 1 98.35%101
1-5 85 96.35%
99
100
101 4 15
101 1 6 2 8,485
48
2. 101 1 6 2
7,977 768
10 6,842 1,875
4,205 1,674
3. 101 1
6 5,688 340 6,579
4. 100
158 71.4%99
67.2%
99 11 24
100 5 11
101 6
1,659
99.8%
5.
49
28
4 1
10
50
99 1.090
100 1.079 101 1-6 1.078
16 1.130
18 101 6 101
942
198 293 491
52.12%(491/942)
6. 101 6 193 78
40
101 6
3,560
20
50
101 6
36 9 4,000
101 1-6 291
5
50 100 100
11 101 6
82
244
()
1. 4 5
100 1 12 35 2,375
97.4% 98%
2. 99 100 47
101 3 15 101
1 6 5 6,694
100 3 4 17 9,898
91.38%
97%
3. 5 1 100
30 9,118 101
22 2,659 146
4. 7 7
51
99
103 1 1
98.3%100 100
80%100 1 1 98%
101 1-5 46 7
84.2% 100
5.
22
1
6
14 2 4
45
6.
132 748
383 6,506
13 154
52
22,475 101
7.
100 2,954
101
101 6 6,598
8. e
100
39 735 101 1 6 13 9,679
3,045
31 Teens
9
1,981
19 87 113
2 6,264
62 51 414 msn
217
53
()
1. 40 64 3 1 55
65 1
101 1 6 112
(100 1 6 )109
2. 100
3 103
6 166 14
416 582
3. 100
18
62.3% 44.6%
4. 100
20 22 7
5 3,843 2
3,958 3 6,418
90%
5. 101
Healthy Lifestyle Healthy Blood Pressure
1,014
887
54
1,987
6. 100-104
101-103
7.
8.
100 536
1,400
9. 483
10. 100
126 50
33
55
2,881
12 5,305 65
11.
100 9 65
81 101 1 6 50 69
29.8 50-69
62.3 65
269 101 1 5
2,504
12.
100
1,333
477
101 6 22 371
1,333 253 770
80%
56
13. 99
100
100 12
13 101 6 21
101
40
101
101 4 11 20
WHO
Working Group on HPH and Age-Friendly Health
Care
14.
WHO-
100 9
20 101 20
57
15.
100 12
22 929 3 424
101 6 22 749 3
292
101 12 5
()
1.
Alliance
For Healthy Cities, AFHC
101 6
58
11
AFHC
2 30
2
34
2.
1 101 6 76 WHO
2 100 12
Health Care Without Harm
HCWH
The First Global Climate
and Health Summit HCWH
UNFCCC 17
17
Climate Change and Public Health: Healthy
Climate, Healthy People, Healthy Economy
WHO TF on HPH and
Environment
WHO The First Global
59
5 101 21 125
(
)46
40
39
3.
1 101 18 142
( 38.6
2 100 13
60
4. 94
101 28
101 6 19
5.
100 12 7,411
303
6.
1 3,699
101
6
293
2
61
101 6 46
7.
1 101 6
9,345
2 100
8.
100
100 1 1,172
70
604 ( 39.84%)
126
()
1. 22
101 60
600 22
62
101 6
3,310
30 8,000 187
2.
368
3.
0800-367-100
101
-
4.
1 18 99
63
2 100 22
1035
138 101
5.
1
2 101 18 143
()
64
1. 100
99 19.8% 19.1%
99 9.1% 8.2%
2. 101 1 6
34 6,416 2,995
2,939 253 8,000
3. 101
4. 101
113
2012 6
5
5. 101 5
(DG SANCO) Ms. Paola Testori Coggi
37
1
6. 101 3 1
200
65
101 6 2,054
96%
7.
101 1 6 4 2,828
2012
3 1,067
8. 98 6 4
101 1 6 96
2,551
()
1.
18 96
17.2% 100 11.3%
2. 97 174.4
100 173.7 0.4% 97
10 94.4 100 93.4 1.1%
105 10%
3. 92 96 41%
94 98 43% 2%
58% 60% 2%
4. 101
66
1 6 279
122.7 38.6
62.3 55.4
2,357 5,836
1,456 868 12,157
664 1,843
5. 101 1
1 3
1 3
HPV101 3 22
6 30 1
2,034 2 2,026
1 1,354 2
1,340
6. 222
69
7.
97 100
39 8
67
101 37
8. 69 101
1 5 8,000 99
1
42%
98 39% 3%
()
1.
101 6 646
30
2.
5
1 4
3.
8
101 6
48 78
17
()
1. DBPR108
68
101 1
FDA 7
2. DBPR104 99
7 30 11 23 FDA
3.
5-MTP
50%
4. 71 101 2
1 2
5. -
69
CKD
2011
10 CKD
6. B
101 4
7. respiratory syncytial
virus, RSV
RSV
8.
70
Sun1
Sun1
2.5
9.
10.
()
1.
65
(Toward Universal Coverage)
71
WHA
(2005)
16
10
101 5 24
DG SANCO
(WMA)(WHPA)
3. APEC
72
(Workshop on Cost-effectiveness of
Strategies for Human Security) APEC
101 8
4. 2011
25 40
2012 101 11 14 16
()
1. 101
12
2. Non-communicable
Disesses-Global priorities and solutions
3.
(1)
101 8 7
73
(2)
(TaiwanIHA)(AMDA)
100 8
130
130 101
2
1
(3)
4.
100 6 26
74
101 8 1
SARS
5.
(1)
()
e-Health
(2)
(3)
101 8
179
()
1.
100
23 146
75
101 8 8 50
2.
100 13
()
101 8 52
699
101/3/01
6
101/4/30
Jewel Mullen 7
Hon.
Jenniffer A. Gonzalez-Colon
101/5/1
6
Excmo. Lic.
101/7/25
Gudy Rivera Estrada 7
76
262
50
300
61
19
6
1
52 699
()
1.
1
2
3
4
2.
1
77
3
4
5
()
1. 22 102
2.
3.
1
2
3
4
()
1.
1
2
3
78
2.
1 101
2
3.
1 2
3
4
()
1.
2. 55 64
3.
4.
5.
6.
HPV
7.
79
()
1.
2. CDC
3.
4. Gastein European Health Forum
()
()
()
80
()
96 98
100
()
1.
2.
3.
4.
()
2143
81
1670
()
1.
2.
3.
4.
5.
()
()
1.
2.
82
IDS
3. (101-105 )
4.
()
1.
2. 101
()
1. 99 4 1
2.
83
()
1.
6 ()
2.
36
() DRG
1. DRG
2.
84
()
()
102 1 1
6
()
1.
101 3 6 25
7 19
85
2.
3.
10-15
4.
()
()
1.
2.
3.
4.
100%
()
1. 71
86
2. 71
()
()
()
103-104 PCV
()
87
()
()
MIT
()
88
()
1.
2.
()
()
()
()
89
1.
2.
290
3.
4. 101
6
5.
100
101 102
101
102
()
90
()
101
()
()
()
()
()
()
()
91
()
()
()
()
()
()
()
()
92